Dysregulated macrophage activity is a characteristic hallmark of intestinal inflammation, especially in Crohn’s disease [277,278], while modulation of mTOR pathways is gaining popularity as a promising therapy for patients with IBD [279], and IL-6 and mTORC1 signaling cascades appear to be inversely correlated [280]. This evidence concerns the gene MTOR and inflammatory bowel disease.